Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Mineralys Therapeutics, Inc. | 63 860 | déclaré | 18 mai 2026 | tx 194+1 366 208−1 539 247 |
| Nivalis Therapeutics, Inc. | 11 368 | déclaré | 04 janv. 2017 | tx 10+154 166−72 624 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 18 mai 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 417 | 15.44 USD | 10b5-1 |
| 18 mai 2026 | SALE | Mineralys Therapeutics, Inc. | 417 | 27.55 USD | 10b5-1 |
| 18 mai 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 417 | 0.00 USD | 10b5-1deriv |
| 13 mai 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 4 166 | 14.25 USD | 10b5-1 |
| 11 mai 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 2 171 | 16.00 USD | 10b5-1 |
| 11 mai 2026 | SALE | Mineralys Therapeutics, Inc. | 2 171 | 29.71 USD | 10b5-1 |
| 12 mai 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 6 348 | 1.08 USD | 10b5-1 |
| 12 mai 2026 | SALE | Mineralys Therapeutics, Inc. | 6 348 | 29.36 USD | 10b5-1 |
| 13 mai 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 3 541 | 10.20 USD | 10b5-1 |
| 13 mai 2026 | SALE | Mineralys Therapeutics, Inc. | 14 056 | 28.58 USD | 10b5-1 |
| 11 mai 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 2 171 | 0.00 USD | 10b5-1deriv |
| 12 mai 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 6 348 | 0.00 USD | 10b5-1deriv |
| 13 mai 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 3 541 | 0.00 USD | 10b5-1deriv |
| 13 mai 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 4 166 | 0.00 USD | 10b5-1deriv |
| 17 mars 2026 | SALE | Mineralys Therapeutics, Inc. | 417 | 25.65 USD | |
| 17 mars 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 417 | 15.44 USD | |
| 17 mars 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 417 | 0.00 USD | deriv |
| 13 mars 2026 | SALE | Mineralys Therapeutics, Inc. | 253 | 27.82 USD | |
| 13 mars 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 4 167 | 14.25 USD | |
| 13 mars 2026 | SALE | Mineralys Therapeutics, Inc. | 10 726 | 25.91 USD | |
| 13 mars 2026 | SALE | Mineralys Therapeutics, Inc. | 3 079 | 27.37 USD | |
| 12 mars 2026 | SALE | Mineralys Therapeutics, Inc. | 6 348 | 27.37 USD | |
| 12 mars 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 6 348 | 1.08 USD | |
| 13 mars 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 3 542 | 10.20 USD | |
| 12 mars 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 6 348 | 0.00 USD | deriv |